Citigroup’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-28,800
| Closed | -$3.94M | – | 6310 |
|
|
2022
Q1 | $3.94M | Sell |
28,800
-1,400
| -5% | -$195K | ﹤0.01% | 1820 |
|
|
2021
Q4 | $5.22M | Buy |
+30,200
| New | +$4.6M | ﹤0.01% | 1799 |
|
|
2021
Q1 | – | Sell |
-4,200
| Closed | -$501K | – | 6495 |
|
|
2020
Q4 | $501K | Sell |
4,200
-31,000
| -88% | -$3.78M | ﹤0.01% | 4207 |
|
|
2020
Q3 | $4.03M | Sell |
35,200
-49,000
| -58% | -$5.79M | ﹤0.01% | 2050 |
|
|
2020
Q2 | $9.6M | Sell |
84,200
-30,300
| -26% | -$3.21M | 0.01% | 1320 |
|
|
2020
Q1 | $9.19M | Buy |
114,500
+87,500
| +324% | +$9.06M | 0.01% | 1225 |
|
|
2019
Q4 | $2.88M | Hold |
27,000
| – | – | ﹤0.01% | 2590 |
|
|
2019
Q3 | $2.89M | Buy |
27,000
+23,200
| +611% | +$2.38M | ﹤0.01% | 2467 |
|
|
2019
Q2 | $387K | Sell |
3,800
-2,800
| -42% | -$269K | ﹤0.01% | 4673 |
|
|
2019
Q1 | $593K | Sell |
6,600
-2,400
| -27% | -$208K | ﹤0.01% | 3998 |
|
|
2018
Q4 | $749K | Sell |
9,000
-80,800
| -90% | -$7.58M | ﹤0.01% | 3690 |
|
|
2018
Q3 | $9.69M | Buy |
89,800
+69,500
| +342% | +$7.62M | 0.01% | 1306 |
|
|
2018
Q2 | $2.23M | Buy |
20,300
+3,700
| +22% | +$385K | ﹤0.01% | 2593 |
|
|
2018
Q1 | $1.67M | Sell |
16,600
-11,300
| -41% | -$1.16M | ﹤0.01% | 2771 |
|
|
2017
Q4 | $2.75M | Sell |
27,900
-17,200
| -38% | -$1.63M | ﹤0.01% | 2374 |
|
|
2017
Q3 | $4.22M | Sell |
45,100
-10,900
| -19% | -$1.16M | ﹤0.01% | 1926 |
|
|
2017
Q2 | $6.22M | Buy |
56,000
+53,200
| +1,900% | +$5.62M | 0.01% | 1524 |
|
|
2017
Q1 | $275K | Sell |
2,800
-7,500
| -73% | -$715K | ﹤0.01% | 4385 |
|
|
2016
Q4 | $947K | Sell |
10,300
-9,500
| -48% | -$819K | ﹤0.01% | 3758 |
|
|
2016
Q3 | $1.68M | Buy |
19,800
+2,200
| +13% | +$185K | ﹤0.01% | 2680 |
|
|
2016
Q2 | $1.43M | Sell |
17,600
-2,200
| -11% | -$168K | ﹤0.01% | 2601 |
|
|
2016
Q1 | $1.42M | Sell |
19,800
-21,100
| -52% | -$1.42M | ﹤0.01% | 2920 |
|
|
2015
Q4 | $2.91M | Sell |
40,900
-15,600
| -28% | -$1.05M | ﹤0.01% | 2191 |
|
|
2015
Q3 | $3.47M | Sell |
56,500
-3,700
| -6% | -$259K | ﹤0.01% | 1982 |
|
|
2015
Q2 | $4.37M | Sell |
60,200
-4,200
| -7% | -$310K | ﹤0.01% | 1851 |
|
|
2015
Q1 | $4.95M | Sell |
64,400
-22,300
| -26% | -$1.6M | ﹤0.01% | 1732 |
|
|
2014
Q4 | $5.81M | Buy |
86,700
+27,900
| +47% | +$1.76M | 0.01% | 1682 |
|
|
2014
Q3 | $3.57M | Buy |
58,800
+22,700
| +63% | +$1.4M | ﹤0.01% | 2111 |
|
|
2014
Q2 | $2.12M | Sell |
36,100
-115,500
| -76% | -$6.76M | ﹤0.01% | 2440 |
|
|
2014
Q1 | $8.78M | Sell |
151,600
-1,900
| -1% | -$102K | 0.01% | 1250 |
|
|
2013
Q4 | $8.22M | Buy |
153,500
+58,500
| +62% | +$3.47M | 0.01% | 1399 |
|
|
2013
Q3 | $5.87M | Sell |
95,000
-6,600
| -6% | -$395K | 0.01% | 1618 |
|
|
2013
Q2 | $6.16M | Buy |
+101,600
| New | +$6.05M | 0.01% | 1437 |
|
Other funds holding DGX
VCM
VPM
EIG
Citigroup's DGX Position: Q1 2026 in Review
Citigroup reduced its Quest Diagnostics (DGX) stake by 7.3% in Q1 2026, selling an estimated $4.41M and leaving 287,123 shares worth $56.3M. The position accounts for 0.02% of the portfolio, ranked #595.
Citigroup first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $60.9M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Citigroup held 287,123 shares of Quest Diagnostics worth $56.3M as of Q1 2026.
- Citigroup sold 22,694 Quest Diagnostics shares in Q1 2026, an estimated $4.41M.
- Quest Diagnostics made up 0.02% of Citigroup's portfolio in Q1 2026, its #595 holding.
- Citigroup first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Quest Diagnostics position peaked at $60.9M in Q3 2025.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.